Mesa Laboratories Future Growth
Future criteria checks 4/6
Mesa Laboratories is forecast to grow earnings and revenue by 108.3% and 8.4% per annum respectively. EPS is expected to grow by 107% per annum. Return on equity is forecast to be 13.9% in 3 years.
Key information
108.3%
Earnings growth rate
107.0%
EPS growth rate
Life Sciences earnings growth | 21.7% |
Revenue growth rate | 8.4% |
Future return on equity | 13.9% |
Analyst coverage | Low |
Last updated | 04 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 254 | 9 | 50 | 59 | 2 |
3/31/2025 | 235 | 2 | 45 | 51 | 3 |
3/31/2024 | 212 | 0 | 41 | 44 | 2 |
12/31/2023 | 213 | 1 | 41 | 44 | N/A |
9/30/2023 | 214 | -1 | 36 | 40 | N/A |
6/30/2023 | 219 | 2 | 36 | 41 | N/A |
3/31/2023 | 219 | 1 | 23 | 28 | N/A |
12/31/2022 | 222 | -1 | 20 | 25 | N/A |
9/30/2022 | 223 | -4 | 28 | 33 | N/A |
6/30/2022 | 200 | -2 | 23 | 27 | N/A |
3/31/2022 | 184 | 2 | 35 | 39 | N/A |
12/31/2021 | 163 | 8 | 39 | 43 | N/A |
9/30/2021 | 143 | 5 | 36 | 38 | N/A |
6/30/2021 | 139 | 4 | 42 | 44 | N/A |
3/31/2021 | 134 | 3 | 35 | 37 | N/A |
12/31/2020 | 130 | -2 | 31 | 32 | N/A |
9/30/2020 | 128 | -2 | 31 | 32 | N/A |
6/30/2020 | 121 | -2 | 27 | 29 | N/A |
3/31/2020 | 118 | 2 | 25 | 27 | N/A |
12/31/2019 | 110 | 5 | 27 | 28 | N/A |
9/30/2019 | 105 | 10 | 27 | 28 | N/A |
6/30/2019 | 104 | 8 | 24 | 25 | N/A |
3/31/2019 | 103 | 7 | 29 | 31 | N/A |
12/31/2018 | 104 | 10 | 28 | 30 | N/A |
9/30/2018 | 101 | -2 | 27 | 29 | N/A |
6/30/2018 | 99 | 0 | 28 | 30 | N/A |
3/31/2018 | 96 | -3 | 23 | 26 | N/A |
12/31/2017 | 94 | -4 | 12 | 17 | N/A |
9/30/2017 | 94 | 11 | N/A | 14 | N/A |
6/30/2017 | 95 | 11 | N/A | 7 | N/A |
3/31/2017 | 94 | 11 | N/A | 17 | N/A |
12/31/2016 | 94 | 12 | N/A | 14 | N/A |
9/30/2016 | 90 | 11 | N/A | 9 | N/A |
6/30/2016 | 88 | 10 | N/A | 18 | N/A |
3/31/2016 | 85 | 11 | N/A | 17 | N/A |
12/31/2015 | 78 | 9 | N/A | 15 | N/A |
9/30/2015 | 76 | 9 | N/A | 16 | N/A |
6/30/2015 | 73 | 10 | N/A | 13 | N/A |
3/31/2015 | 71 | 10 | N/A | 11 | N/A |
12/31/2014 | 68 | 11 | N/A | 9 | N/A |
9/30/2014 | 64 | 10 | N/A | 11 | N/A |
6/30/2014 | 58 | 9 | N/A | 10 | N/A |
3/31/2014 | 53 | 9 | N/A | 12 | N/A |
12/31/2013 | 50 | 8 | N/A | 12 | N/A |
9/30/2013 | 48 | 8 | N/A | 12 | N/A |
6/30/2013 | 47 | 8 | N/A | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MLI's forecast earnings growth (108.3% per year) is above the savings rate (0.7%).
Earnings vs Market: MLI's earnings (108.3% per year) are forecast to grow faster than the German market (18.7% per year).
High Growth Earnings: MLI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MLI's revenue (8.4% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: MLI's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MLI's Return on Equity is forecast to be low in 3 years time (13.9%).